Page last updated: 2024-08-17

levodopa and Depression

levodopa has been researched along with Depression in 170 studies

Research

Studies (170)

Timeframe	Studies, this research(%)	All Research%
pre-1990	63 (37.06)	18.7374
1990's	19 (11.18)	18.2507
2000's	37 (21.76)	29.6817
2010's	46 (27.06)	24.3611
2020's	5 (2.94)	2.80

Authors

Authors	Studies
Cerquera-Cleves, C; Dulski, J; Koziorowski, D; Kwiatek-Majkusiak, J; Milanowski, L; Pentela-Nowicka, J; Ross, OA; Sławek, J; Wszolek, ZK	1
Bekhbat, M; Felger, JC; Haroon, E; Li, Z; Lucido, MJ; Mehta, ND; Miller, AH; Treadway, MT; Woolwine, BJ	1
Angelopoulou, E; Bougea, A; Fotakopoulos, G; Fragkiadaki, S; Georgakopoulou, VE; Karpodini, CC; Kontaxopoulou, D; Koros, C; Koutedakis, Y; Papageorgiou, SG; Piperi, C; Stanitsa, E	1
Bartlett, MJ; Besselsen, DG; Cowen, SL; Dollish, HK; Doyle, KP; Falk, T; Farrell, DC; Flores, AJ; Heien, ML; Parent, KL; Sherman, SJ; Smidt, SI; Stancati, JA; Steece-Collier, K; Ye, T	1
Abbasi, MH; Esmaeili, S; Habibi, SA; Shahidi, GA	1
Fu, YT; Huang, JY; Li, J; Liu, CF; Liu, JY; Ma, LJ; Mao, CJ; Wang, Y; Zhang, HJ	1
Barber, TR; Ben-Shlomo, Y; Crabbe, M; Drew, D; Hu, MTM; Husain, M; Lawton, M; Muhammed, K; Quinnell, T; Rolinski, M; Zaiwalla, Z	1
Hagell, P; Horne, M; Iwarsson, S; Nilsson, MH; Odin, P; Rosqvist, K	1
Cova, I; Priori, A	1
Chung, SJ; Kim, JS; Lee, JJ; Lee, PH; Lee, Y; Moon, H; Oh, JS; Sohn, YH	1
Amato, N; Galati, S; Kaelin-Lang, A; Manconi, M; Möller, JC; Sarasso, S; Staedler, C; Stanzione, P	1
Hamed, M; Lazarescu, A; Shetty, A; Suchowersky, O; Tremain, G	1
Azevedo, LF; Castro-Lopes, J; Cavaco, S; Damásio, J; Fernandes, J; Gonçalves, A; Mendes, A; Moreira, I; Vila-Chã, N	1
Caspell-Garcia, CJ; Coffey, CS; Espay, AJ; Foster, ED; Uribe, L; Weintraub, D	1
Baig, F; Barber, TR; Ben-Shlomo, Y; Hu, MT; Kelly, MJ; Klein, JC; Lawton, MA; Lo, C; Ruffmann, C	1
Pandey, S	1
Brown, JA; Conyers, S; Dearborn, JT; Diggs-Andrews, KA; Gutmann, DH; Izumi, Y; Tokuda, K; Wozniak, DF; Yuede, CM; Zorumski, CF	1
Bloem, BR; de Greef, MH; Dontje, ML; Kamsma, YP; Krijnen, WP; Munneke, M; Speelman, AD; Stolk, RP; van der Schans, CP; van Nimwegen, M	1
Harries, A; Hodson, J; Kausar, J; Mitchell, R; Ngoga, D; Pall, H	1
Matsui, K; Oguru, M; Oka, N; Okuda, B; Tachibana, H; Toda, K; Yamanishi, T	1
Takeda, A	1
An, J; Chan, P; Gu, Z; Wang, C; Zhang, H	1
Evans, AH; Griffiths, RI; Horne, M; Kettlewell, J; Kotschet, K; McGregor, S	1
De Luka, SR; Kostić, VS; Milovanović, B; Pekmezović, T; Svetel, M	1
Chiu, WH; Depboylu, C; Hermanns, G; Höglinger, GU; Maurer, L; Oertel, WH; Ries, V; Windolph, A	1
Amato, L; Davoli, M; De Crescenzo, F; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P	1
Bellante, F; Dethy, S; Zegers de Beyl, D	1
Fukuda, K	1
Baybas, S; Dirican, A; Dogan, GB; Dogan, VB; Koksal, A	1
Benetin, J; Hanakova, M; Harsany, J; Martinkova, J; Minar, M; Singliarova, H; Valkovic, P	1
Franklin, A; Miguelez, C; Raskind, MA; Sikkema, C; Szot, P; Ugedo, L; Vidaurrazaga, I; Wang, Y; Wilkinson, CW	1
Huang, T; Jiang, Y; Tan, ZG; Zhou, Q	1
García-Sánchez, C; Gironell, A; Kulisevsky, J; Martínez-Corral, M; Pagonabarraga, J; Pascual-Sedano, B	1
Sethi, K	1
Bungener, C; Montel, SR	1
Aarsland, D; Ballard, CG; Ehrt, U; Francis, PT; Larsen, JP; Perry, EK; Perry, RH; Piggott, MA; Sharp, SI; Ziabreva, I	1
Comella, C; Elmer, L; Hauser, RA; Lyons, KE; Pahwa, R; Simuni, T; Weintraub, D	1
Marinus, J; van Hilten, JJ; van Rooden, SM; Verbaan, D; Visser, M	1
Letro, GH; Quagliato, EM; Viana, MA	1
Cohen, H; Pourcher, E; Rémillard, S	1
Asmus, F; Berg, D; Reimold, M; Schöls, L; Synofzik, M	1
Amaro-Junior, E; Andrade, LA; Borges, V; Bressan, RA; Felicio, AC; Ferraz, HB; Godeiro-Junior, C; Hoexter, MQ; Moriyama, TS; Shih, MC; Silva, SM	1
Angoa-Perez, M; Bishop, C; Eskow Jaunarajs, KL; Kuhn, DM	1
Gupta, A; Lang, AE	1
Akat, S; Emre, M; Gurvit, H; Hanagasi, HA; Yazici, J	1
Hou, B; Jiang, T; Liu, R	1
Bishop, C; Button, T; Deak, T; Dupre, KB; Eskow Jaunarajs, KL; Ostock, CY	1
Baker, K; Burn, D; Lord, S; Nieuwboer, A; Rochester, L	1
Barone, P	1
Domino, EF; Jutkiewicz, EM; Ohmura, Y	1
Egeland, M; Svenningsson, P; Zhang, X	1
Franch, O; Kurtis, MM	1
Schnitzler, A; Südmeyer, M; Wojtecki, L	1
Amato, L; Davoli, M; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P	1
Kostic, VS; Petrovic, M; Stefanova, E; Stojkovic, T; Ziropadja, Lj	1
Joutsa, J; Kaasinen, V; Martikainen, K; Vahlberg, T	1
Broussolle, E; Castrioto, A; Chabardès, S; Fraix, V; Kistner, A; Klinger, H; Krack, P; Lhommée, E; Mertens, P; Pollak, P; Quesada, JL; Schmitt, E; Thobois, SC	1
Berrocoso, E; Mico, JA; Miguelez, C; Ugedo, L	1
D'Andreamatteo, G; Iacono, D; Luciano, AL; Onofrj, M; Thomas, A	1
Kleiner-Fisman, G; Lang, AE; Lozano, A; Miyasaki, J; Saint-Cyr, JA	1
Agid, Y; Bejjani, BP; Houeto, JL; Mallet, L; Mesnage, V; Welter, ML	1
Bilbao, G; Garibi, J; Gómez, JC; Lambarri, I; Lezcano, E; Madoz, P; Molano, A; Zarranz, JJ	1
Bares, M; Dostál, V; Ehler, E; Fanfrdlová, Z; Fiedler, J; Klajblová, H; Kulist'ák, P; Rektor, I; Rektorová, I; Ressner, P; Svátová, J; Urbánek, K; Velísková, J	2
Ongini, E	1
Kostić, VS	1
Bezard, E; Carroll, P; Diaz, J; Griffon, N; Gross, C; Guillin, O; Lammers, C; Le Foll, B; Schwartz, JC; Sokoloff, P; Stark, H	1
Ludin, HP	1
Baba, Y; Putzke, JD; Uitti, RJ; Whaley, NR; Wszolek, ZK	1
Berdeaux, G; Clarke, CE; Deschaseaux-Voinet, C; Khoshnood, B; Péchevis, M; Vieregge, P; Ziegler, M	1
Chigir', IP; Fedorova, NV	1
Herkes, GK; McKay, D; Meagher, LJ; Needham, M	1
Fuchs, G; Hahne, M; Klein, W; Müller, T; Schwarz, M	1
Bowers, D; Fernandez, H; Foote, K; Kirsch-Darrow, L; Mikos, A; Miller, K; Okun, M; Springer, U	1
Arbouw, ME; Egberts, TC; Guchelaar, HJ; Movig, KL; Neef, C	1
Waldvogel, D	1
Bertucci Filho, D; Teive, HA; Werneck, LC	1
Angersbach, D; Buchwald, B; Jost, WH	1
Juckel, G; Klein, J; Kupsch, A; Lee, T; Morgenstern, R; Mundt, A; Petrus, D; von Rumohr, A; Winter, C	1
Erikh, I; Schlesinger, I; Yarnitsky, D	1
Borah, A; Mohanakumar, KP	1
Nuller, JL; Ostroumova, MN	1
Klusha, VE; Kozlovskaia, MM; Svirskis, ShV; Val'dman, AV	1
Jörg, J	1
Burns, R	1
Gelenberg, AJ	1
Baldessarini, RJ	1
Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ	1
Aabro, E; Andersen, J; Gulmann, N; Hjelmsted, A; Pedersen, HE	1
Balldin, J; Edén, S; Granérus, AK; Modigh, K; Svanborg, A; Wålinder, J; Wallin, L	1
Danielczyk, W	1
McKenna, P; Pratt, RT; Stern, GM; Ward, C	1
Carter, JH; Maricle, RA; Nutt, JG	1
Lang, A; Männistö, PT; Rauhala, P; Vasar, E	1
Brown, D; Factor, SA; Molho, ES; Podskalny, GD	1
Standaert, DG; Stern, MB	1
Lang, AE; Riley, DE	1
Marder, K; Mayeux, R; Stern, Y; Tang, MX	1
Baas, H; Fischer, PA; Stecker, K	1
Berlin, I; Launay, JM; Olivares, R; Puech, AJ; Said, S; Spreux-Varoquaux, O	1
Olanow, CW	1
Stallibrass, C	1
Camicioli, R; Ganzini, L; Young, BK	1
Almeida, OP; Tamai, S	1
Chouinard, S; Fahn, S	1
Fetoni, V; Girotti, F; Monza, D; Soliveri, P; Testa, D	1
Agid, Y; Arnulf, I; Bejjani, BP; Bonnet, AM; Cornu, P; Damier, P; Dormont, D; Pidoux, B; Samson, Y; Thivard, L	1
Giladi, N; Kandinov, B; Korczyn, AD; Orlov, Y; Paleacu, D; Shabtai, H; Simon, ES; Treves, TA	1
Goto, K; Miwa, C; Morita, Y; Shimode, H; Shinjo, H; Ueki, A	1
Karlsen, K; Larsen, JP; Tandberg, E	1
Fung, VS; Hely, MA; Morris, JG	1
Ball, J	1
Miyoshi, K	1
Balestre, E; Bioulac, B; Chrysostome, V; Ghorayeb, I; Tison, F; Yekhlef, F	1
Messina, FS	1
Cohen, KL	1
Chevalier, JF; Ginestet, D	1
Gold, PW; Goodwin, FK; Rebar, R; Sack, R; Wehr, T	1
Fann, WE; Stafford, JR	1
Brauman, H; Linkowski, P; Mendlewicz, J	1
Gold, PW; Goodwin, FK	1
Benkert, O	1
Luchins, D	1
Van Praag, HM	1
Zarifian, E	1
McFarland, HR	1
Wirz-Justice, A	2
Frazer, A; Mendels, J	1
Agnoli, A; Casacchia, M; Ruggieri, S	1
Aksenova, IO	1
Brunswick, D; Frazer, A; Maany, I; Mendels, J	1
Kawai, I; Shingu, K; Yamada, K	1
Gershon, S; Shopsin, B	1
Marsden, CD; Mindham, RH; Parkes, JD	1
Couto, B; Freitas, MR; Mattos, JP; Oliveira, C	1
Maeda, K	1
Bunney, WE	1
Kirstein, L; Leichter, SB; Martin, ND	1
Dostal, T; Kabes, J; Krsiak, M; Masek, K; Pöschlová, N; Volsan, O	2
Dunner, DL; Fieve, RR	1
Burns, D; Frazer, A; Mendels, J; Stinnett, JL	1
Girke, W; Xenakis, Ch	1
Bermanzohn, PC; Lipper, S	1
Altman, N; Glassman, A; Gruen, PH; Halpern, FS; Sachar, EJ; Sassin, J	1
Ballivet, J; Boudry, C; Gisselmann, A; Marin, A	1
Jansen, EN; Kölling, P	1
Berger, W; Bitschnau, W; Karamat, E; Kemmler, GW; Poewe, W; Ransmayr, G; Schmidhuber-Eiler, B	1
Driver, PS	1
Bolduc, PL; Preziosi, TJ; Robinson, RG; Starkstein, SE	1
Kraus, P; Kuhn, W; Przuntek, H	1
Dubois, B	1
Berthier, ML; Bolduc, PL; Mayberg, HS; Preziosi, TJ; Robinson, RG; Starkstein, SE	1
Gangat, AE; Naidoo, LR; Simpson, MA	1
Agnoli, A; Baronti, F; Denaro, A; Ruggieri, S; Stocchi, F	1
Kassirer, JP; Kopelman, RI	1
Baas, H; Fischer, PA	1
Kamenetskiĭ, VK; Nuller, IuL	1
Carlini, EA; Frochtengarten, ML; Maluf, E; Villares, JC	1
Fonda, D	1
Ginestet, D	1
Singer, E	1
Chakravorty, NK	1
Dostál, T; Kabes, J; Taussigová, D; Vinar, O	1
Dunner, DL	1
Diamond, SG; Markham, CH; Treciokas, LJ	1
Fischer, PA; Jacobi, P; Maxion, H; Schneider, E	1
Feldman, RD; Pearlman, CA; Sax, DS	1

Reviews

29 review(s) available for levodopa and Depression

Article	Year
Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review. Medicina (Kaunas, Lithuania), 2023, Aug-12, Volume: 59, Issue:8 Topics: Acupuncture Therapy; Antidepressive Agents, Tricyclic; Depression; Humans; Levodopa; Parkinson Disease	2023
Diagnostic biomarkers for Parkinson's disease at a glance: where are we? Journal of neural transmission (Vienna, Austria : 1996), 2018, Volume: 125, Issue:10 Topics: alpha-Synuclein; Biomarkers; Brain; Cognition Disorders; Constipation; Depression; Early Diagnosis; Genetic Predisposition to Disease; Humans; Inflammation; Levodopa; Metabolomics; Microbiota; Movement Disorders; Neuroimaging; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Symptom Assessment; Vision Disorders	2018
Parkinson's disease: recent advances. The Journal of the Association of Physicians of India, 2012, Volume: 60 Topics: Antiparkinson Agents; Brain; Depression; Dopamine Agonists; Humans; Levodopa; Parkinson Disease	2012
Dopamine agonists for the treatment of cocaine dependence. The Cochrane database of systematic reviews, 2015, May-27, Issue:5 Topics: Amantadine; Antidepressive Agents; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic; Selection Bias	2015
Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials. Clinical interventions in aging, 2016, Volume: 11 Topics: Deep Brain Stimulation; Depression; Globus Pallidus; Humans; Levodopa; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome	2016
Levodopa unresponsive symptoms in Parkinson disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23 Suppl 3 Topics: Antiparkinson Agents; Anxiety; Depression; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Sweating; Xerostomia	2008
Treatment of early Parkinson's disease. Part 2. European neurology, 2009, Volume: 61, Issue:4 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Clinical Trials as Topic; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Olfaction Disorders; Pain; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Time Factors	2009
Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment. Neuroscience and biobehavioral reviews, 2011, Volume: 35, Issue:3 Topics: Animals; Antiparkinson Agents; Anxiety; Depression; Disease Models, Animal; Humans; Levodopa; Neurotransmitter Agents; Parkinson Disease	2011
Treatment of depressive symptoms in Parkinson's disease. European journal of neurology, 2011, Volume: 18 Suppl 1 Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Depression; Desipramine; Dopamine Agonists; Humans; Levodopa; Nortriptyline; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2011
[Current treatment strategies for Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:12 Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor	2011
Dopamine agonists for the treatment of cocaine dependence. The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12 Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic	2011
Comt inhibition in the treatment of Parkinson's disease: neuroprotection and future perspectives. Advances in experimental medicine and biology, 2004, Volume: 541 Topics: Animals; Antiparkinson Agents; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Depression; Dyskinesia, Drug-Induced; Forecasting; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Psychoses, Substance-Induced	2004
Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. International review of neurobiology, 2004, Volume: 59 Topics: Animals; Brain-Derived Neurotrophic Factor; Denervation; Depression; Dopamine; Dopamine Agents; Gene Expression Regulation, Developmental; Humans; Levodopa; Limbic System; Neuronal Plasticity; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Stress, Physiological	2004
[Idiopathic Parkinson's disease: practical hints for the treatment]. Praxis, 2005, Jul-27, Volume: 94, Issue:30-31 Topics: Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Benserazide; Cholinesterase Inhibitors; Clozapine; Dementia; Depression; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease; Quality of Life; Sleep Wake Disorders; Time Factors	2005
[Medical treatment of Parkinson's disease]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:1 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Cholinergic Antagonists; Controlled Clinical Trials as Topic; Dementia; Depression; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Dyskinesias; Hallucinations; Humans; Levodopa; Middle Aged; Multicenter Studies as Topic; Pain; Parkinson Disease; Quality of Life; Therapeutic Equivalency; Time Factors	2007
Parkinson's disease: drug-induced psychiatric states. Advances in neurology, 1995, Volume: 65 Topics: Aged; Anxiety; Bipolar Disorder; Clozapine; Depression; Electroconvulsive Therapy; Humans; Levodopa; Lisuride; Male; Ondansetron; Parkinson Disease; Psychoses, Substance-Induced; Sexual Dysfunctions, Psychological	1995
Update on the management of Parkinson's disease. The Medical clinics of North America, 1993, Volume: 77, Issue:1 Topics: Depression; Diagnosis, Differential; Dopamine Agents; Hallucinations; Humans; Levodopa; Parkinson Disease; Selegiline	1993
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment. Drugs & aging, 1997, Volume: 10, Issue:5 Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Dementia; Depression; Dopamine Agonists; Electroconvulsive Therapy; Humans; Levodopa; Memantine; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Risk Factors; Serotonin Antagonists	1997
Depression in multiple system atrophy: a case report. Psychiatry and clinical neurosciences, 2000, Volume: 54, Issue:4 Topics: Antidepressive Agents; Antiparkinson Agents; Brain; Depression; Female; Humans; Levodopa; Middle Aged; Multiple System Atrophy; Tomography, Emission-Computed, Single-Photon; Urinary Bladder Diseases; Urodynamics	2000
Treatment of Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2000, Volume: 7, Issue:6 Topics: Age Factors; Animals; Antiparkinson Agents; Anxiety; Catechol O-Methyltransferase Inhibitors; Depression; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease	2000
[Parkinson's disease]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:8 Topics: Antiparkinson Agents; Depression; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline	2001
Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review. Metabolism: clinical and experimental, 1977, Volume: 26, Issue:10 Topics: Anorexia; Antipsychotic Agents; Depression; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Endocrine System Diseases; Ethanol; Hormones; Humans; Hypokalemia; Levodopa; Liver Cirrhosis; Metabolic Diseases; Morphine; Obesity; Phenothiazines; Pituitary Function Tests; Pituitary Gland; Starvation; Uremia	1977
Drug interactions with guanidinium antihypertensives. Drugs, 1977, Volume: 13, Issue:1 Topics: Amphetamines; Anesthetics; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Contraceptives, Oral; Depression; Drug Interactions; Drug Therapy, Combination; Guanidines; Humans; Hypertension; Insulin; Levodopa; Nasal Decongestants; Psychotic Disorders; Vasoconstrictor Agents	1977
Biogenic amines and affective disorders. A critical analysis. International pharmacopsychiatry, 1976, Volume: 11, Issue:3 Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Brain Chemistry; Clinical Trials as Topic; Depression; Electroconvulsive Therapy; Fenclonine; Fusaric Acid; Humans; Levodopa; Lithium; Methyldopa; Methyltyrosines; Methysergide; Monoamine Oxidase Inhibitors; Phenylketonurias; Reserpine; Tryptophan	1976
[Therapeutically resistant depressive states]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1979, Volume: 79, Issue:4 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depersonalization; Depression; Drug Resistance; Electroconvulsive Therapy; Half-Life; Humans; Hypochondriasis; Levodopa; Middle Aged; Monoamine Oxidase Inhibitors; Sleep Deprivation; Syndrome; Thyrotropin; Tryptophan	1979
[Side-effects of L-dopa therapy]. Deutsche medizinische Wochenschrift (1946), 1975, Oct-17, Volume: 100, Issue:42 Topics: Arrhythmias, Cardiac; Basal Ganglia Diseases; Depression; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Sex Factors; Time Factors; Vomiting	1975
Medication as a potential cause of depression. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1986, Aug-16, Volume: 70, Issue:4 Topics: Antihypertensive Agents; Antipsychotic Agents; Cardiovascular Agents; Cimetidine; Contraceptives, Oral; Depression; Humans; Levodopa; Steroids	1986
Parkinson's disease in the elderly: psychiatric manifestations. Geriatrics, 1985, Volume: 40, Issue:4 Topics: Aged; Amantadine; Depression; Humans; Levodopa; Mood Disorders; Parasympatholytics; Parkinson Disease; Personality Disorders	1985
Parkinson's disease and levodopa. A five-year follow-up and review. The Western journal of medicine, 1974, Volume: 121, Issue:3 Topics: Activities of Daily Living; Adolescent; Adult; Aged; Animals; Athetosis; Basal Ganglia; Chorea; Corpus Striatum; Dementia; Depression; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Sexual Behavior; Substantia Nigra; Vomiting	1974

Trials

22 trial(s) available for levodopa and Depression

Article	Year
Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Molecular psychiatry, 2022, Volume: 27, Issue:10 Topics: Adult; Anhedonia; Depression; Depressive Disorder, Major; Dopamine; Humans; Inflammation; Levodopa; Magnetic Resonance Imaging; Neural Pathways; Reward	2022
Motor changes during sertraline treatment in depressed patients with Parkinson's disease. European journal of neurology, 2008, Volume: 15, Issue:9* Topics: Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cohort Studies; Depression; Depressive Disorder; Dopamine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Severity of Illness Index	2008
Patterns of motor and non-motor features in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2009, Volume: 80, Issue:8 Topics: Aged; Antiparkinson Agents; Cohort Studies; Depression; Factor Analysis, Statistical; Female; Humans; Levodopa; Linear Models; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Movement; Parkinson Disease; Reproducibility of Results; Treatment Outcome	2009
Affect in Parkinson's disease: validation of the two-factor approach. Journal of the neurological sciences, 2010, Feb-15, Volume: 289, Issue:1-2 Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Depression; Dopamine; Female; Humans; Hyperkinesis; Hypokinesia; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Reproducibility of Results; Serotonin; Time Factors	2010
Psychostimulant effect of levodopa: reversing sensitisation is possible. Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:1 Topics: Anxiety; Basal Ganglia; Deep Brain Stimulation; Depression; Dopamine Agonists; Dyskinesia, Drug-Induced; Euphoria; Female; Humans; Levodopa; Male; Middle Aged; Motivation; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Subthalamic Nucleus	2013
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. European journal of neurology, 2003, Volume: 10, Issue:4 Topics: Activities of Daily Living; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Depression; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pergolide; Placebos; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome	2003
Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy. European journal of neurology, 2005, Volume: 12, Issue:1 Topics: Aged; Analysis of Variance; Cognition Disorders; Depression; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Statistics, Nonparametric	2005
Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA. Acta neurologica Scandinavica, 1980, Volume: 62, Issue:4 Topics: Aged; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nortriptyline; Parkinson Disease	1980
Monoamine oxidase A and B activities in heavy smokers. Biological psychiatry, 1995, Dec-01, Volume: 38, Issue:11 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Blood Platelets; Blood Pressure; Cotinine; Depression; Female; Glycine; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Norepinephrine; Resorcinols; Smoking	1995
Experience with tranylcypromine in early Parkinson's disease. Journal of neural transmission. Supplementum, 1998, Volume: 52 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Erectile Dysfunction; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders; Time Factors; Tranylcypromine; Tyramine	1998
Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy. Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:4 Topics: Antiparkinson Agents; Depression; Humans; Levodopa; Middle Aged; Mood Disorders; Multiple System Atrophy; Parkinson Disease	1999
Studies on pituitary hormones and releasing hormones in depression and sexual impotence. Progress in brain research, 1975, Volume: 42 Topics: 5-Hydroxytryptophan; Benserazide; Bipolar Disorder; Clinical Trials as Topic; Depression; Erectile Dysfunction; Female; Fenclonine; Humans; Imipramine; Insulin; Levodopa; Male; Pituitary Hormone-Releasing Hormones; Pituitary Hormones	1975
Biogenic amines and affective disorders. A critical analysis. International pharmacopsychiatry, 1976, Volume: 11, Issue:3 Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Brain Chemistry; Clinical Trials as Topic; Depression; Electroconvulsive Therapy; Fenclonine; Fusaric Acid; Humans; Levodopa; Lithium; Methyldopa; Methyltyrosines; Methysergide; Monoamine Oxidase Inhibitors; Phenylketonurias; Reserpine; Tryptophan	1976
Use of L-DOPA in depression. Advances in biochemical psychopharmacology, 1977, Volume: 16 Topics: Catecholamines; Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Levodopa	1977
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry. Pharmacology, 1978, Volume: 16 Suppl 1 Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents	1978
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability. Psychological medicine, 1976, Volume: 6, Issue:1 Topics: Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interview, Psychological; Levodopa; Male; Mental Status Schedule; Methyldopa; Middle Aged; Parkinson Disease; Placebos; Recurrence; Trihexyphenidyl	1976
The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease. Neurologia, neurocirugia, psiquiatria, 1976, Volume: 17, Issue:4 Topics: Amantadine; Clinical Trials as Topic; Depression; Dibenzazepines; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Placebos	1976
Affective disorder: studies with amine precursors. The American journal of psychiatry, 1975, Volume: 132, Issue:2 Topics: Adult; Antidepressive Agents; Biogenic Amines; Bipolar Disorder; Brain; Brain Chemistry; Clinical Trials as Topic; Depression; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Models, Biological; Placebos; Remission, Spontaneous; Tryptophan	1975
Amine precursors and depression. Archives of general psychiatry, 1975, Volume: 32, Issue:1 Topics: Adult; Aged; Bipolar Disorder; Clinical Trials as Topic; Depression; Humans; Levodopa; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Recurrence; Tryptophan	1975
Depression treatment in Parkinson's disease. DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:2 Topics: Antidepressive Agents, Tricyclic; Carbidopa; Depression; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Humans; Levodopa; Nortriptyline; Parkinson Disease	1991
Therapeutic efficacy of R-(-)-deprenyl as adjuvant therapy in advanced parkinsonism. Journal of neural transmission. Supplementum, 1987, Volume: 25 Topics: Aged; Clinical Trials as Topic; Depression; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline; Thioxanthenes	1987
Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom. European neurology, 1974, Volume: 12, Issue:5-6 Topics: Aged; Amides; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior; Clinical Trials as Topic; Depression; Dopa Decarboxylase; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levodopa; Male; Melanocyte-Stimulating Hormones; Middle Aged; Oligopeptides; Parkinson Disease; Pituitary Hormone-Releasing Hormones; Placebos; Psychomotor Disorders; Sleep Wake Disorders	1974

Other Studies

120 other study(ies) available for levodopa and Depression

Article	Year
L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome. Parkinsonism & related disorders, 2022, Volume: 100 Topics: Antiparkinson Agents; Depression; Dyskinesia, Drug-Induced; Dystonia; Dystonic Disorders; Humans; Hypoventilation; Levodopa; Parkinson Disease; Parkinsonian Disorders	2022
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia. Experimental neurology, 2020, Volume: 333 Topics: Anesthetics, Dissociative; Animals; Antiparkinson Agents; Brain-Derived Neurotrophic Factor; Dendritic Spines; Depression; Drug Repositioning; Dyskinesia, Drug-Induced; Ketamine; Levodopa; Male; MAP Kinase Signaling System; Neurons; Rats; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases	2020
Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 79 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Depression; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Pramipexole; Psychotic Disorders; Quality of Life	2020
Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients. Pain practice : the official journal of World Institute of Pain, 2018, Volume: 18, Issue:1 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Depression; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Musculoskeletal Pain; Pain; Pain Measurement; Parkinson Disease; Polysomnography; Quality of Life; Sleep; Sleep Wake Disorders; Sleep, REM	2018
Apathy in rapid eye movement sleep behaviour disorder is common and under-recognized. European journal of neurology, 2018, Volume: 25, Issue:3 Topics: Aged; Aged, 80 and over; Apathy; Cognition; Cohort Studies; Depression; Dopamine Agonists; Emotions; Female; Humans; Levodopa; Male; Mass Screening; Middle Aged; Neuropsychological Tests; Parkinson Disease; Polysomnography; REM Sleep Behavior Disorder	2018
Levodopa Effect and Motor Function in Late Stage Parkinson's Disease. Journal of Parkinson's disease, 2018, Volume: 8, Issue:1 Topics: Accelerometry; Aged; Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Depression; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesias; Female; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychotropic Drugs; Severity of Illness Index; Sweden	2018
The presence of depression in de novo Parkinson's disease reflects poor motor compensation. PloS one, 2018, Volume: 13, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Cognition; Cohort Studies; Depression; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tropanes	2018
Levodopa-induced dyskinesia in Parkinson disease: Sleep matters. Annals of neurology, 2018, Volume: 84, Issue:6 Topics: Actigraphy; Adult; Aged; Antiparkinson Agents; Depression; Dyskinesia, Drug-Induced; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Psychiatric Status Rating Scales; Sleep Wake Disorders; Statistics, Nonparametric	2018
A case of Perry Syndrome responding to intestinal infusion of carbidopa/levodopa. Parkinsonism & related disorders, 2019, Volume: 61 Topics: Antiparkinson Agents; Carbidopa; Depression; Drug Combinations; Female; Gels; Humans; Hypoventilation; Infusions, Parenteral; Jejunostomy; Levodopa; Middle Aged; Parkinsonian Disorders	2019
Unveiling the relationship between central parkinsonian pain and motor symptoms in Parkinson's disease. European journal of pain (London, England), 2019, Volume: 23, Issue:8 Topics: Aged; Antiparkinson Agents; Anxiety; Depression; Disabled Persons; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neuralgia; Parkinson Disease; Surveys and Questionnaires	2019
Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease. Journal of the neurological sciences, 2019, Jul-15, Volume: 402 Topics: Affect; Aged; Antidepressive Agents; Antiparkinson Agents; Cognition; Depression; Disease Progression; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Treatment Outcome	2019
Predictors of motor complications in early Parkinson's disease: A prospective cohort study. Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:8 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cohort Studies; Depression; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index	2019
Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice. PloS one, 2013, Volume: 8, Issue:6 Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Dopamine Agents; Electrophysiology; Female; Humans; Integrases; Levodopa; Male; Maze Learning; Memory Disorders; Mice; Mice, Knockout; Mice, Transgenic; Motivation; Neurofibromatosis 1; Neurofibromin 1	2013
Quantifying daily physical activity and determinants in sedentary patients with Parkinson's disease. Parkinsonism & related disorders, 2013, Volume: 19, Issue:10 Topics: Age Factors; Aged; Antiparkinson Agents; Anxiety; Body Mass Index; Depression; Educational Status; Energy Metabolism; Female; Guidelines as Topic; Humans; Levodopa; Linear Models; Male; Middle Aged; Motor Activity; Netherlands; Parkinson Disease; Physical Fitness; Sedentary Behavior; Self Efficacy; Sex Factors; Socioeconomic Factors	2013
Deep brain stimulation improves survival in severe Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:1 Topics: Aged; Antiparkinson Agents; Cause of Death; Deep Brain Stimulation; Depression; Female; Humans; Kaplan-Meier Estimate; Levodopa; Logistic Models; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Regression Analysis; Subthalamic Nucleus; Survival; Survival Analysis; Treatment Outcome	2014
Clinical correlates of anhedonia in patients with Parkinson's disease. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:12 Topics: Aged; Anhedonia; Antiparkinson Agents; Anxiety; Depression; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life	2013
[Treatment & management guidelines 2011 for Parkinson disease]. Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11 Topics: Antiparkinson Agents; Cognition Disorders; Depression; Dopamine Agonists; Drug Administration Schedule; Humans; Japan; Levodopa; Movement Disorders; Neurology; Parkinson Disease; Practice Guidelines as Topic; Societies, Medical	2013
Non-motor symptoms in treated and untreated Chinese patients with early Parkinson's disease. The Tohoku journal of experimental medicine, 2014, Volume: 232, Issue:2 Topics: Age Factors; Antiparkinson Agents; China; Cohort Studies; Constipation; Depression; Dopamine Agonists; Humans; Levodopa; Logistic Models; Parkinson Disease; Sex Factors; Sleep Wake Disorders; Time Factors	2014
A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease. PloS one, 2014, Volume: 9, Issue:2 Topics: Aged; Anxiety; Apathy; Compulsive Behavior; Conditioning, Psychological; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesias; Humans; Hypokinesia; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Weights and Measures	2014
When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease? Vojnosanitetski pregled, 2014, Volume: 71, Issue:4 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Anxiety; Autonomic Nervous System; Case-Control Studies; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Psychiatric Status Rating Scales; Serbia; Severity of Illness Index; Time Factors	2014
Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease. Neuropharmacology, 2015, Volume: 95 Topics: Animals; Antiparkinson Agents; Anxiety; Benzothiazoles; Depression; Hippocampus; Levodopa; Male; Mice, Inbred C57BL; Neurogenesis; Neurons; Olfactory Bulb; Oxidopamine; Parkinsonian Disorders; Pramipexole; Random Allocation	2015
Depression, anxiety and non-motor symptoms on initiation of intrajejunal levodopa/carbidopa therapy. Acta neurologica Belgica, 2016, Volume: 116, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Anxiety; Carbidopa; Depression; Drug Combinations; Female; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Time Factors	2016
Integrated theory to unify status among schizophrenia and manic depressive illness. Medical hypotheses, 2015, Volume: 85, Issue:4 Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biopterins; Bipolar Disorder; Blood-Brain Barrier; Depression; Depression, Postpartum; Dopamine; Female; Hallucinations; Humans; Kynurenic Acid; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurotransmitter Agents; Paranoid Disorders; Premenstrual Syndrome; Schizophrenia; Seasonal Affective Disorder; Serotonin; Serotonin Syndrome; Tyrosine	2015
Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Depression; Depressive Disorder; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires	2015
Pain in Parkinson's Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life. PloS one, 2015, Volume: 10, Issue:8 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Cross-Sectional Studies; Depression; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease; Quality of Life; Surveys and Questionnaires	2015
Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine. Neuropharmacology, 2016, Volume: 101 Topics: Action Potentials; Adrenergic Agents; Animals; Catecholamines; Depression; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Food Preferences; Levodopa; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Neurons; Oxidopamine; Phenazines; Sucrose; Swimming; Time Factors	2016
Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus. Surgical neurology, 2009, Volume: 72, Issue:2 Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cognition; Deep Brain Stimulation; Depression; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Education as Topic; Psychomotor Performance; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Time Factors	2009
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Autopsy; Cerebral Cortex; Dementia; Depression; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Temporal Lobe	2008
Pain in Parkinson's disease. Arquivos de neuro-psiquiatria, 2009, Volume: 67, Issue:3A Topics: Antiparkinson Agents; Depression; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Pain; Pain Measurement; Parkinson Disease; Prospective Studies	2009
Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2010, Jan-30, Volume: 25, Issue:2 Topics: Affect; Depression; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Dopamine Agents; Female; Humans; Indoles; Levodopa; Middle Aged; Parkinsonian Disorders; Radionuclide Imaging; Treatment Outcome	2010
Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology, 2010, Volume: 211, Issue:1 Topics: Aged; Brain; Case-Control Studies; Depression; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Middle Aged; Organotechnetium Compounds; Parkinson Disease; Protein Binding; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Tropanes	2010
Drug-induced cranial myoclonus. Movement disorders : official journal of the Movement Disorder Society, 2010, Oct-15, Volume: 25, Issue:13 Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Depression; Female; Humans; Levodopa; Male; Middle Aged; Myoclonus; Parkinsonian Disorders	2010
Pain is common in Parkinson's disease. Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Depression; Female; Humans; Levodopa; Male; Middle Aged; Pain; Pain Measurement; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales	2011
Deep-brain stimulation for Parkinson's disease. The New England journal of medicine, 2010, 09-02, Volume: 363, Issue:10 Topics: Depression; Dopamine Agents; Electric Stimulation Therapy; Globus Pallidus; Humans; Levodopa; Parkinson Disease; Subthalamic Nucleus	2010
Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat. Behavioural pharmacology, 2010, Volume: 21, Issue:7 Topics: Amygdala; Animals; Anxiety; Behavioral Research; Biogenic Monoamines; Chromatography, High Pressure Liquid; Corpus Striatum; Depression; Dopamine; Dopamine Agents; Hippocampus; Humans; Levodopa; Male; Models, Animal; Motor Activity; Oxidopamine; Parkinson Disease; Prefrontal Cortex; Rats; Rats, Sprague-Dawley	2010
Gait variability in Parkinson's disease: an indicator of non-dopaminergic contributors to gait dysfunction? Journal of neurology, 2011, Volume: 258, Issue:4 Topics: Aged; Attention; Depression; Dopamine Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Regression Analysis; Severity of Illness Index; Time Factors	2011
L-DOPA attenuates nicotine withdrawal-induced behaviors in rats. Pharmacology, biochemistry, and behavior, 2011, Volume: 98, Issue:4 Topics: Animals; Behavior, Animal; Depression; Dopamine Agents; Levodopa; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Smoking Cessation; Substance Withdrawal Syndrome	2011
Antidepressant-like properties of sarizotan in experimental Parkinsonism. Psychopharmacology, 2011, Volume: 218, Issue:4 Topics: Animals; Antidepressive Agents; Antiparkinson Agents; Behavior, Animal; Benserazide; Cell Proliferation; Dentate Gyrus; Depression; Disease Models, Animal; Doublecortin Protein; Drug Combinations; Levodopa; Locomotion; Male; Organic Chemicals; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Swimming	2011
Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy. Parkinsonism & related disorders, 2011, Volume: 17, Issue:10 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Depression; Female; Flupenthixol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Tetrabenazine	2011
Apathy and depression in Parkinson's disease: the Belgrade PD study report. Parkinsonism & related disorders, 2012, Volume: 18, Issue:4 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Apathy; Community Health Planning; Depression; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prevalence; Regression Analysis; Serbia	2012
Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism & related disorders, 2012, Volume: 18, Issue:10 Topics: Aged; Amantadine; Antidepressive Agents; Antiparkinson Agents; Data Collection; Depression; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; Risk Factors; Self Report; Sex Distribution; Surveys and Questionnaires	2012
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats. Neuropharmacology, 2013, Volume: 67 Topics: Animals; Antidepressive Agents; Contraindications; Depression; Drug Therapy, Combination; Fluoxetine; Levodopa; Locus Coeruleus; Male; Morpholines; Motor Activity; Rats; Rats, Sprague-Dawley; Reboxetine; Treatment Outcome	2013
Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology, 2003, Jan-14, Volume: 60, Issue:1 Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Electroencephalography; Humans; Levodopa; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Parkinsonian Disorders; Polysomnography; REM Sleep Behavior Disorder	2003
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology, 2003, Jan-14, Volume: 60, Issue:1 Topics: Confusion; Depression; Dopamine Agonists; Dysarthria; Electric Stimulation Therapy; Follow-Up Studies; Humans; Levodopa; Motor Activity; Parkinson Disease; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome	2003
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology, 2003, Jan-14, Volume: 60, Issue:1 Topics: Confusion; Depression; Dopamine Agonists; Electric Stimulation Therapy; Follow-Up Studies; Levodopa; Mood Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease; Quality of Life; Social Behavior Disorders; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome	2003
[Neuropsychological changes and bilateral subthalamic deep brain stimulation in Parkinson's disease]. Neurologia (Barcelona, Spain), 2003, Volume: 18, Issue:3 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Cohort Studies; Depression; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Male; Memory; Middle Aged; Motor Skills; Neuropsychological Tests; Parkinson Disease; Quality of Life; Statistics as Topic; Subthalamic Nucleus	2003
Adenosine A(2A) receptors in nonlocomotor features of Parkinson's disease: introduction. Neurology, 2003, Dec-09, Volume: 61, Issue:11 Suppl 6 Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Central Nervous System; Depression; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Receptor, Adenosine A2A; Sleep Wake Disorders	2003
Gender and the Parkinson's disease phenotype. Journal of neurology, 2005, Volume: 252, Issue:10 Topics: Activities of Daily Living; Age of Onset; Analysis of Variance; Antiparkinson Agents; Chi-Square Distribution; Cohort Studies; Databases, Factual; Depression; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Phenotype; Retrospective Studies; Sex Factors; Time Factors; Tremor	2005
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. European journal of neurology, 2005, Volume: 12, Issue:12 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Depression; Dyskinesias; Europe; Female; Health Care Costs; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life	2005
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:6 Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome	2006
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:8 Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries	2006
Diagnostic aspects of early Parkinson's disease. Journal of neurology, 2006, Volume: 253 Suppl 4 Topics: Antiparkinson Agents; Brain; Cognition Disorders; Depression; Humans; Levodopa; Parkinson Disease; Perceptual Disorders	2006
Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli. Brain : a journal of neurology, 2006, Volume: 129, Issue:Pt 12 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antiparkinson Agents; Arousal; Blinking; Depression; Dopamine Agents; Emotions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Photic Stimulation; Reaction Time; Reflex, Startle; Severity of Illness Index	2006
Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients. European journal of clinical pharmacology, 2007, Volume: 63, Issue:2 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Cohort Studies; Databases, Factual; Depression; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Selective Serotonin Reuptake Inhibitors	2007
Early-onset Parkinson's disease and depression. Arquivos de neuro-psiquiatria, 2007, Volume: 65, Issue:1 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Psychiatric Status Rating Scales; Risk Factors	2007
[Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy]. Fortschritte der Neurologie-Psychiatrie, 2007, Volume: 75, Issue:4 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Disability Evaluation; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	2007
Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats. Behavioural brain research, 2007, Dec-03, Volume: 184, Issue:2 Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Functional Laterality; Helplessness, Learned; Levodopa; Male; Nerve Degeneration; Neurons; Oxidopamine; Rats; Rats, Wistar; Reaction Time; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area	2007
Paradoxical kinesia at war. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:16 Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Anxiety; Cues; Depression; Dyskinesias; Fear; Female; Humans; Israel; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Stress, Psychological; Warfare	2007
Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats. Cellular and molecular neurobiology, 2007, Volume: 27, Issue:8 Topics: Animals; Brain; Depression; Dopamine; Levodopa; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Serotonin; Swimming; Time Factors	2007
Resistance to inhibiting effect of dexamethasone in patients with endogenous depression. Acta psychiatrica Scandinavica, 1980, Volume: 61, Issue:2 Topics: 11-Hydroxycorticosteroids; Adolescent; Adult; Aged; Anti-Anxiety Agents; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Diazepam; Drug Synergism; Female; Humans; Levodopa; Male; Middle Aged; Serotonin; Tryptophan	1980
[Psychopharmacologic spectrum of melanostatin]. Biulleten' eksperimental'noi biologii i meditsiny, 1980, Volume: 89, Issue:6 Topics: Aggression; Amantadine; Animals; Behavior, Animal; Biogenic Amines; Brain Chemistry; Catalepsy; Cats; Depression; Emotions; Fever; Haloperidol; Humans; Levodopa; Motor Activity; MSH Release-Inhibiting Hormone; Reserpine	1980
[Therapeutic concept in Parkinson disease]. Deutsche medizinische Wochenschrift (1946), 1983, Jul-15, Volume: 108, Issue:28-29 Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor	1983
Difficulties in long term management of Parkinson's disease. Australian family physician, 1984, Volume: 13, Issue:5 Suppl Topics: Dementia; Depression; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa; Parkinson Disease; Time Factors	1984
New antidepressant drugs: a clinical perspective. Psychopharmacology bulletin, 1984,Spring, Volume: 20, Issue:2 Topics: Antidepressive Agents; Depression; Humans; Levodopa; Tryptophan	1984
Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacology bulletin, 1984,Spring, Volume: 20, Issue:2 Topics: Biogenic Amines; Catecholamines; Depression; Humans; Levodopa; Monoamine Oxidase Inhibitors; Serotonin; Tryptophan; Tyrosine	1984
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment. Neurology, 1982, Volume: 32, Issue:5 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine	1982
Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon. Journal of neural transmission, 1980, Volume: 47, Issue:1 Topics: Aged; Depression; Electroconvulsive Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1980
[Crises in the course of Parkinson's disease]. Wiener medizinische Wochenschrift (1946), 1980, Feb-29, Volume: 130, Issue:4 Topics: Aged; Amantadine; Bromocriptine; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders	1980
Electroconvulsive therapy in Parkinsonian patients with the "on-off" syndrome. Journal of neural transmission, 1980, Volume: 49, Issue:1-2 Topics: Depression; Dyskinesia, Drug-Induced; Dystonia; Electroconvulsive Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1980
Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:3 Topics: Affect; Aged; Anxiety; Arousal; Carbidopa; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease	1995
Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression. European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3 Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Depression; Desipramine; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Levodopa; Male; Motor Activity; Nitriles; Nitrophenols; Rats; Rats, Wistar; Swimming; Tolcapone	1995
The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology, 1993, Volume: 43, Issue:8 Topics: Aged; Depression; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Restless Legs Syndrome; Urinary Incontinence	1993
Antecedent clinical features associated with dementia in Parkinson's disease. Neurology, 1993, Volume: 43, Issue:9 Topics: Aged; Dementia; Depression; Humans; Levodopa; Middle Aged; Odds Ratio; Parkinson Disease; Prevalence; Psychoses, Substance-Induced; Risk Factors	1993
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:1 Topics: Aged; Dementia; Depression; Depressive Disorder; Disability Evaluation; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease; Psychomotor Performance; Reference Values; Tremor	1993
A 61-year-old man with Parkinson's disease. JAMA, 1996, Mar-06, Volume: 275, Issue:9 Topics: 1-Naphthylamine; Antiparkinson Agents; Carbidopa; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Family Practice; Humans; Levodopa; Male; Middle Aged; Neurology; Neuroprotective Agents; Parkinson Disease; Selegiline; Sertraline; Vitamin E	1996
An evaluation of the Alexander Technique for the management of disability in Parkinson's disease--a preliminary study. Clinical rehabilitation, 1997, Volume: 11, Issue:1 Topics: Aged; Body Image; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Quality of Life; Rehabilitation; Social Adjustment	1997
Nortriptyline for the treatment of depression in progressive supranuclear palsy. Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:8 Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Dopamine Agents; Female; Fluoxetine; Humans; Levodopa; Nortriptyline; Remission Induction; Supranuclear Palsy, Progressive	1997
Transient acute depression induced by high-frequency deep-brain stimulation. The New England journal of medicine, 1999, May-13, Volume: 340, Issue:19 Topics: Acute Disease; Aged; Antiparkinson Agents; Brain; Depression; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Parkinson Disease; Substantia Nigra; Thalamic Nuclei	1999
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:1 Topics: Age Distribution; Age of Onset; Aged; Antiparkinson Agents; Dementia; Depression; Disease Progression; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Prevalence; Psychotic Disorders; Risk Factors	2000
Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: Age of Onset; Aged; Antiparkinson Agents; Case-Control Studies; Dementia; Depression; Diabetes Mellitus; Drug Tolerance; Fatigue; Female; Humans; Levodopa; Male; Movement Disorders; Neurologic Examination; Norway; Outpatients; Parkinson Disease; Prevalence; Psychomotor Performance; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires	2000
Current advances in Parkinson's disease. Trends in neurosciences, 2001, Volume: 24, Issue:7 Topics: Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Brain Stem; Catechols; Depression; Dopamine Agonists; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles	2001
Sleep disorders and their determinants in multiple system atrophy. Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 72, Issue:6 Topics: Aged; Antiparkinson Agents; Depression; Female; Humans; Incidence; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders	2002
Caesium ion: antagonism to chlorpromazine- and L-dopa- produced behavioural depression in mice. The Journal of pharmacy and pharmacology, 1975, Volume: 27, Issue:11 Topics: Animals; Antidepressive Agents; Behavior, Animal; Cesium; Chlorpromazine; Depression; Humans; Levodopa; Male; Mice; Motor Activity; Time Factors	1975
[Iatrogenic depression (author's transl)]. L'Encephale, 1979, Volume: 5, Issue:5 Suppl Topics: Antihypertensive Agents; Antipsychotic Agents; Appetite Depressants; Bipolar Disorder; Contraceptives, Oral, Hormonal; Depression; Diagnosis, Differential; Humans; Levodopa	1979
Growth-hormone and prolactin response to levodopa in affective illness. Lancet (London, England), 1976, Dec-11, Volume: 2, Issue:7998 Topics: Adult; Bipolar Disorder; Depression; Female; Growth Hormone; Humans; Levodopa; Male; Menopause; Middle Aged; Prolactin	1976
Growth hormone and prolactin response to levodopa in affective illness. Lancet (London, England), 1977, Mar-19, Volume: 1, Issue:8012 Topics: Adult; Bipolar Disorder; Depression; Female; Growth Hormone; Humans; Levodopa; Menopause; Middle Aged; Prolactin	1977
Neuroendocrine responses to levodopa in affective illness. Lancet (London, England), 1977, May-07, Volume: 1, Issue:8019 Topics: Aged; Bipolar Disorder; Depression; Estrogens; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sex Factors	1977
Editorial: Miracle cures in Parkinson's disease. British medical journal, 1975, Jul-05, Volume: 3, Issue:5974 Topics: Chloramphenicol; Cyclic AMP; Depression; Electroconvulsive Therapy; Humans; Levodopa; Parkinson Disease	1975
[Neuro-endocrine disorders in depression: their importance for the study of the pathogenesis of depression]. Nederlands tijdschrift voor geneeskunde, 1977, Dec-10, Volume: 121, Issue:50 Topics: Adrenocorticotropic Hormone; Catecholamines; Depression; Female; Humans; Hydrocortisone; Hypothalamus; Insulin; Levodopa; Luteinizing Hormone; Menopause; Neurosecretory Systems; Peptides; Pituitary Gland; Pituitary-Adrenal System; Prolactin; Serotonin; Synaptic Transmission; Thyrotropin-Releasing Hormone	1977
[Dopa and dopamine agonists in depression (author's transl)]. L'Encephale, 1979, Volume: 5, Issue:5 Suppl Topics: Animals; Brain; Depression; Dihydroxyphenylalanine; Dopamine; Humans; Levodopa; Receptors, Dopamine; Synaptic Transmission	1979
Treating parkinsonism in the era of levodopa. American family physician, 1975, Volume: 12, Issue:3 Topics: Amantadine; Antidepressive Agents; Anxiety; Depression; Histamine H1 Antagonists; Humans; Levodopa; Occupational Therapy; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Tranquilizing Agents	1975
Theoretical and therapeutic potential of indolamine precursors in affective disorders. Neuropsychobiology, 1977, Volume: 3, Issue:4 Topics: 5-Hydroxytryptophan; Amino Acids; Bipolar Disorder; Depression; Emotions; Female; Humans; Levodopa; Male; Phenylalanine; Serotonin; Sex Factors; Tryptophan; Tyrosine	1977
A study of growth hormone release in depression. Neuropsychobiology, 1979, Volume: 5, Issue:5 Topics: Adult; Apomorphine; Bipolar Disorder; Depression; Growth Hormone; Humans; Levodopa; Male; Middle Aged	1979
Three cases of unipolar delusional depression responsive to L-dopa. Folia psychiatrica et neurologica japonica, 1979, Volume: 33, Issue:4 Topics: Adult; Delusions; Depression; Female; Humans; Levodopa; Male; Middle Aged; Psychomotor Agitation	1979
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495). Neuropsychobiology, 1978, Volume: 4, Issue:1 Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bromocriptine; Depression; Female; Hostility; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Piperazines; Piribedil; Receptors, Dopamine; Syndrome	1978
Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly. The Kobe journal of medical sciences, 1976, Volume: 22, Issue:4 Topics: Acromegaly; Adult; Anorexia Nervosa; Arginine; Blood Glucose; Depression; Female; Growth Hormone; Humans; Infusions, Parenteral; Injections, Intravenous; Insulin; Levodopa; Male; Middle Aged; Thyrotropin-Releasing Hormone	1976
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases. Advances in biochemical psychopharmacology, 1977, Volume: 16 Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia	1977
Thyroid function and growth hormone secretion in amitriptyline-treated depression. The American journal of psychiatry, 1977, Volume: 134, Issue:11 Topics: Adult; Amitriptyline; Depression; Female; Growth Hormone; Humans; Levodopa; Middle Aged; Remission, Spontaneous; Secretory Rate; Stimulation, Chemical; Thyroid Function Tests	1977
[Preclinical conception and clinical uses of L-dopa in combination with tricyclic antidepressives in pharmacoresistant depressions (author's transl)]. Ceskoslovenska psychiatrie, 1976, Volume: 72, Issue:5 Topics: Animals; Antidepressive Agents, Tricyclic; Depression; Drug Resistance; Drug Synergism; Humans; Levodopa; Rats	1976
Tricyclic antidepressants and depletion of brain catecholamines. Preclinical and clinical studies with L-DOPA [proceedings]. Activitas nervosa superior, 1976, Volume: 18, Issue:3 Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Brain; Depression; Dopamine; Humans; Levodopa; Norepinephrine; Nortriptyline; Rats	1976
Theoretical and therapeutic potential of indoleamine precursors (2). Nihon rinsho. Japanese journal of clinical medicine, 1976, Oct-10, Volume: 34, Issue:10 Topics: Catecholamines; Depression; Humans; Levodopa	1976
Letter: Electroconvulsive therapy in patients with parkinsonism. The American journal of psychiatry, 1975, Volume: 132, Issue:4 Topics: Amantadine; Atropine; Depression; Diphenhydramine; Electroconvulsive Therapy; Female; Humans; Levodopa; Methohexital; Middle Aged; Parkinson Disease; Succinylcholine; Suicide	1975
Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration. Archives of general psychiatry, 1975, Volume: 32, Issue:4 Topics: Adult; Age Factors; Aged; Depression; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Levodopa; Male; Menopause; Middle Aged; Pituitary Gland; Sex Factors	1975
[Clinical and biochemical considerations on depressive states occuring during parkinsonian syndrome treated by L-Dopa]. L'Encephale, 1976, Volume: 2, Issue:2 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Catecholamines; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary	1976
[Parkinsonism following addition of fluoxetine to treatment with neuroleptics or carbamazepine]. Nederlands tijdschrift voor geneeskunde, 1992, Apr-11, Volume: 136, Issue:15 Topics: Depression; Female; Fluoxetine; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary	1992
Slowing of high-speed memory scanning in Parkinson's disease is related to the severity of parkinsonian motor symptoms. Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:4 Topics: Aged; Depression; Female; Humans; Intelligence Tests; Levodopa; Male; Mental Recall; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Reaction Time; Severity of Illness Index; Synaptic Transmission	1990
Depression in Parkinson's disease. The Journal of nervous and mental disease, 1990, Volume: 178, Issue:1 Topics: Cognition Disorders; Depression; Dose-Response Relationship, Drug; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Psychiatric Status Rating Scales	1990
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid. Acta neurologica Scandinavica. Supplementum, 1989, Volume: 126 Topics: Benserazide; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Glycols; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Parkinson Disease; Phenethylamines; Selegiline	1989
[The mental state of parkinsonian patients]. La Revue du praticien, 1989, Mar-09, Volume: 39, Issue:8 Topics: Cognition Disorders; Dementia; Depression; Humans; Levodopa; Mental Disorders; Parkinson Disease	1989
Depression and cognitive impairment in Parkinson's disease. Brain : a journal of neurology, 1989, Volume: 112 ( Pt 5) Topics: Cognition; Cognition Disorders; Depression; Humans; Language Tests; Levodopa; Neuropsychological Tests; Parkinson Disease; Regression Analysis	1989
The role of MAO-b inhibitors in the treatment of Parkinson's disease. Journal of neural transmission. Supplementum, 1986, Volume: 22 Topics: Adult; Aged; Depression; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline	1986
A modern medical Descartes. Hospital practice (Office ed.), 1987, Sep-15, Volume: 22, Issue:9 Topics: Depression; Diagnostic Errors; Drug Interactions; Humans; Hypertension; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors	1987
[Features of affective disorders in patients with vascular parkinsonism]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1987, Volume: 87, Issue:4 Topics: Aged; Anxiety; Cerebrovascular Disorders; Depression; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Mood Disorders; Parasympatholytics; Parkinson Disease, Secondary	1987
Depressive symptoms and the dexamethasone suppression test in parkinsonian patients. Biological psychiatry, 1987, Volume: 22, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Depression; Dexamethasone; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease	1987
The psychiatrist attitudes and therapeutic means when faced with resistant depressions. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1974, Volume: 7, Issue:4 Topics: Amitriptyline; Amphetamine; Antidepressive Agents; Autistic Disorder; Depression; Drug Resistance; Drug Therapy, Combination; Humans; Imipramine; Levodopa; Lithium; Suicide; Thyrotropin-Releasing Hormone	1974
The effect of treatment with levodopa on Parkinson patients' social functioning and outlook on life. Journal of chronic diseases, 1974, Volume: 27, Issue:11-12 Topics: Activities of Daily Living; Aged; Attitude to Health; Depression; Family; Female; Humans; Interview, Psychological; Leisure Activities; Levodopa; Life Style; Male; Parkinson Disease; Social Behavior; Social Environment; Work	1974
Treatment of blepharospasm with levodopa. Postgraduate medical journal, 1974, Volume: 50, Issue:586 Topics: Aged; Blepharospasm; Depression; Eyelid Diseases; Female; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease	1974
L-dopa and tricyclic antidepressants in affective disorders. A pilot study. Activitas nervosa superior, 1974, Volume: 16, Issue:3 Topics: Adult; Amitriptyline; Depression; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Nausea; Nortriptyline; Pilot Projects; Vomiting	1974
Proceedings: Amine precursors in depression: studies combining L-DOPA and L-tryptophan. Psychopharmacology bulletin, 1974, Volume: 10, Issue:4 Topics: Animals; Depression; Humans; Levodopa; Tryptophan	1974
Psychiatric aspects of L-dopa therapy of Parkinson's disease. Psychiatry in medicine, 1972, Volume: 3, Issue:1 Topics: Adult; Aged; Delirium; Depression; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1972